WELL DIFFERENTIATED LIPOSARCOMA

Clinical trials for WELL DIFFERENTIATED LIPOSARCOMA explained in plain language.

Never miss a new study

Get alerted when new WELL DIFFERENTIATED LIPOSARCOMA trials appear

Sign up with your email to follow new studies for WELL DIFFERENTIATED LIPOSARCOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1

New drug duo aims to halt aggressive fat tissue cancer

Disease control Recruiting now

This study is testing whether combining two drugs, mirdametinib and palbociclib, is safe and effective for people with advanced liposarcoma that has spread, returned, or cannot be surgically removed. Researchers will first find the safest dose of mirdametinib to give with a fixed…

Matched conditions: WELL DIFFERENTIATED LIPOSARCOMA

Phase: PHASE1, PHASE2 • Sponsor: Memorial Sloan Kettering Cancer Center • Aim: Disease control

Last updated Mar 30, 2026 14:35 UTC

WELL DIFFERENTIATED LIPOSARCOMA

Get alerted when new WELL DIFFERENTIATED LIPOSARCOMA trials appear

New drug duo aims to halt aggressive fat tissue cancer